NeueHealth, Inc. - Laporan Laba Rugi (TTM)

NeueHealth, Inc.
US ˙ NYSE ˙ US10920V1070

Laporan Laba Rugi (TTM)

Laporan Laba Rugi NeueHealth, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 515 1,883 2,700 3,427 1,513 819 -145 -1,031 751 871 1,020 1,096 1,161 1,105 1,033 997 937 907 890
Change (%) 265.77 43.38 26.91 -55.85 -45.85 -117.73 609.45 -172.89 15.95 17.07 7.46 5.95 -4.78 -6.51 -3.53 -6.04 -3.13 -1.86
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 452 1,601 2,273 3,012 1,294 789 15 -884 663 744 858 932 997 933 866 822 742 706 675
Change (%) 254.32 41.93 32.54 -57.04 -39.03 -98.07 -5,910.39 -175.03 12.17 15.38 8.66 6.90 -6.35 -7.23 -5.05 -9.73 -4.85 -4.43
% of Revenue 87.77 85.02 84.17 87.90 85.53 96.31 -10.47 85.74 88.26 85.38 84.15 85.09 85.85 84.44 83.79 82.47 79.23 77.83 75.79
Gross Operating Profit 63 282 428 415 219 30 -160 -147 88 127 162 163 164 172 167 175 195 201 216
Change (%) 347.93 51.60 -3.06 -47.20 -86.20 -631.44 -8.41 -160.01 44.36 26.92 1.08 0.54 4.74 -2.62 4.35 11.29 3.43 7.14
% of Revenue 12.23 14.98 15.83 12.10 14.47 3.69 110.47 14.26 11.74 14.62 15.85 14.91 14.15 15.56 16.21 17.53 20.77 22.17 24.21
SG&A 221 539 712 924 527 415 233 9 354 337 328 338 314 301 302 271 271 253 227
Change (%) 143.75 31.93 29.85 -42.99 -21.16 -43.84 -96.13 3,827.40 -4.87 -2.59 2.85 -6.98 -4.06 0.06 -10.23 -0.03 -6.68 -10.14
% of Revenue 42.97 28.64 26.35 26.96 34.81 50.69 -160.56 -0.88 47.19 38.71 32.21 30.84 27.07 27.28 29.19 27.16 28.90 27.84 25.49
R&D
Change (%)
% of Revenue
OpEx 681 2,153 3,001 3,965 1,856 1,236 281 -840 1,048 1,116 1,218 1,290 1,329 1,252 1,184 1,109 1,028 973 916
Change (%) 215.89 39.43 32.10 -53.19 -33.40 -77.24 -398.65 -224.75 6.44 9.15 5.92 3.05 -5.79 -5.43 -6.35 -7.26 -5.35 -5.89
% of Revenue 132.35 114.30 111.15 115.71 122.66 150.89 -193.67 81.53 139.53 128.10 119.43 117.72 114.50 113.29 114.60 111.24 109.81 107.28 102.88
Operating Income -167 -269 -301 -538 -343 -417 -427 -190 -297 -245 -198 -194 -168 -147 -151 -112 -92 -66 -26
Change (%) 61.69 11.81 78.70 -36.28 21.58 2.32 -55.38 56.02 -17.59 -19.04 -1.98 -13.33 -12.75 2.73 -25.70 -18.07 -28.05 -61.13
% of Revenue -32.35 -14.30 -11.15 -15.71 -22.66 -50.89 293.67 18.47 -39.53 -28.10 -19.43 -17.72 -14.50 -13.29 -14.60 -11.24 -9.81 -7.28 -2.88
Interest Expense -1 -5 -6 -7 -8 -4 -7 -13 -19 -28 -33 -38 -33 -28 -24 -19 -22 -25
Change (%) 758.61 34.00 15.09 8.95 -48.31 81.31 73.67 51.43 45.49 18.18 14.43 -12.71 -15.17 -16.36 -20.95 19.82 12.35
% of Revenue -0.03 -0.17 -0.18 -0.48 -0.96 2.80 0.72 -1.71 -2.23 -2.77 -3.05 -3.29 -3.02 -2.74 -2.37 -2.00 -2.47 -2.83
Net Income -248 -266 -293 -534 -1,185 -1,355 -1,585 -1,601 -1,456 -1,435 -1,273 -1,591 -1,151 -992 -938 -362 -135 -131 -82
Change (%) 7.20 9.93 82.46 121.81 14.35 16.99 1.02 -9.10 -1.39 -11.28 24.90 -27.61 -13.82 -5.46 -61.45 -62.76 -3.10 -37.22
% of Revenue -48.25 -14.14 -10.84 -15.59 -78.31 -165.39 1,091.20 155.38 -193.77 -164.80 -124.90 -145.17 -99.19 -89.78 -90.79 -36.28 -14.38 -14.38 -9.20

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista